WILX Home ·  Station Info
   
News  ·   Sports  ·   Weather  ·   Job Search  ·   Blogs  ·   Contests  ·   iWitness Photo/Video  ·   10toGo  ·   Instant Alert  ·   World News
Recipes · Restaurants · Community · School Closings · Lottery · Entertainment · Money · Breakroom · Apartment Guide · Repair Don’t Replace · Summer Guide
Health Information Update from the FDA
Pollen Counts Expected to Spike Save Email Print
Posted: 5:55 PM Apr 27, 2007
Last Updated: 5:56 PM Apr 27, 2007
Reporter: Jessica Aspiras
Email Address: jessica.aspiras@wilx.com

A | A | A

18-year-old Chiara Zanoni just finished her appointment at the Okemos Allergy Center. A couple of years ago she was diagnosed with seasonal allergies. And it's this time of year she really notices the symptoms.

"Itchy eyes. Plugged up ears. Itchy ears."

"The trees pollinate in waves one after the other over about a two month period starting in April and ending in June," says Dr. Lawrence Hennessey of the Okemos Allergy Center.

He says weather also plays a huge factor in pollen counts.

"If it's raining, it will wash the pollen out of the air."

It's exactly the type of weather the area's seen the past few days. This weekend's change will in turn cause pollen counts to surge nearly to the top of pollen-dot-com's twelve point scale.

"About the only way to completely avoid pollen is to stay indoors, in air conditioning, or go someplace where that plant isn't pollinating and that's hard to do," says Dr. Hennessey.

As far as over the counter medications go, any antihistamine that contains loratadine can provide relief without drowsiness.

"If they find they have to use them constantly to get relief then it's time to see your doctor," he says.

That's what Zanoni did. And while she says the illness is a hassle to control, she's willing to deal.

"It's better to take medication than to have annoying symptoms."

Dr. Hennessey also recommends not going outdoors in the mid to late morning hours when pollen counts peak.

More Stories
Summer Remedies to Keep Kids Healthy and Happy Over the Holiday Weekend

Painkiller Safety

National Health Care Debate Hits Michigan

Babies Born Healthier

What's Going Around

One Woman's Fight With Kidney Disease

Obama Voicing Confidence on Health Care Changes

What's Going Around

Post Your Comments
First Name:
Location:
Enter Comments: characters left
Email (optional):
By posting this comment I have read and agree to the Terms of Use and Privacy Policy:
You must agree to the Terms of Service to continue.
CDC Data and Statistics Widget. Flash Player 9 is required.
MedWatch Safety Alerts from the FDA
  • Lantus (insulin glargine)
    FDA reviewing safety data regarding possible risk for cancer in patient with diabetes.
  • Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics)
    FDA requires new Boxed Warnings and patient Medication Guides highlighting the risk of serious neuropsychiatric symptoms
  • Nestle Toll House Prepackaged, Refrigerated Cookie Dough
    FDA and the CDC are warning consumers not to eat any varieties of prepackaged Nestle Toll House refrigerated cookie dough due to the risk of contamination with E. coli O157:H7 (a bacterium that causes food borne illness). Since March 2009 there have been 66 reports of illness across 28 states. Twenty-five persons were hospitalized; 7 with a severe complication called Hemolytic Uremic Syndrome. No one has died.E. coli O157:H7 causes abdominal cramping, vomiting and a diarrheal illness, often with bloody stools. Most healthy adults can recover completely within a week. Young children and the elderly are at highest risk for developing HUS,which can lead to serious kidney damage and even death.
  • Stamina-Rx Dietary Supplement Products
    FDA and Hi-Tech Pharmaceuticals notified patients and healthcare professionals of a nationwide recall of all product sold under the name Stamina-Rx. Hi-Tech was notified by the FDA that the lab analysis of Stamina-Rx samples found that the product contained the undeclared ingredient − benzamidenafil − a Phosphodiesterase Type 5 inhibitor.
  • Cefepime (marketed as Maxipime) Update of Ongoing Safety Review
    FDA finished its analysis of a possible risk of higher death with cefepime and has determined that the data do not indicate a higher rate of death in cefepime-treated patients.